IFF reports Q3 adjusted EPS $1.05, consensus $1.02

Reports Q3 revenue $2.7b, consensus $2.63B. “Our third quarter results demonstrate continued execution in a tough operating environment,” said Erik Fyrwald, CEO of IFF (IFF). “Sales momentum in Scent and Taste remain solid, supported by strong new win contributions. This performance helped offset short-term pressures in Health and Biosciences – which we are addressing by strengthening our innovation and commercial capabilities – and a sales reduction in Food Ingredients as we focus on driving higher margins.”